Jefferies Group Reiterates “Buy” Rating for Medidata Solutions (MDSO)
Medidata Solutions (NASDAQ:MDSO)‘s stock had its “buy” rating reiterated by analysts at Jefferies Group in a research report issued to clients and investors on Friday, American Banking and Market News reports. They currently have a $145.00 price objective on the stock, up from their previous price objective of $105.00. Jefferies Group’s price target points to a potential upside of 17.79% from the stock’s previous close.
Medidata Solutions (NASDAQ:MDSO) traded down 1.01% on Friday, hitting $121.855. The stock had a trading volume of 292,009 shares. Medidata Solutions has a 1-year low of $31.30 and a 1-year high of $99.79. The stock’s 50-day moving average is $89.9 and its 200-day moving average is $71.32. The company has a market cap of $3.128 billion and a P/E ratio of 148.67.
Medidata Solutions (NASDAQ:MDSO) last released its earnings data on Thursday, October 24th. The company reported $0.40 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.33 by $0.07. The company had revenue of $70.90 million for the quarter, compared to the consensus estimate of $70.74 million. During the same quarter in the prior year, the company posted $0.29 earnings per share. The company’s quarterly revenue was up 27.1% on a year-over-year basis.
A number of other analysts have also recently weighed in on MDSO. Analysts at B. Riley raised their price target on shares of Medidata Solutions from $75.00 to $93.00 in a research note to investors on Tuesday. They now have a “neutral” rating on the stock. Separately, analysts at Credit Suisse raised their price target on shares of Medidata Solutions from $94.00 to $108.00 in a research note to investors on Friday, September 13th. Finally, analysts at Raymond James raised their price target on shares of Medidata Solutions from $50.00 to $58.00 in a research note to investors on Thursday, August 22nd. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $90.44.
Medidata Solutions, Inc (NASDAQ:MDSO) is a global provider of software-as-a-service (SaaS), clinical technology solutions.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.